BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3854 related articles for article (PubMed ID: 6974886)

  • 1. A Clq solid phase microenzymatic assay for the detection of soluble immune complexes.
    Cordiali Fei P; Natali PG
    Ric Clin Lab; 1981; 11(3):207-14. PubMed ID: 6974886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
    Antes U; Heinz HP; Loos M
    J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of circulating immune complexes and of their component immunoglobulin classes M, G, and A with a C1q-ELISA].
    Sequeira Peña GA; Herrmann D; Vogt KH; Jäger L
    Allerg Immunol (Leipz); 1991; 37(1):37-45. PubMed ID: 2063729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the C1q solid-phase binding assay for immune complexes. A clinical and laboratory study.
    Scullion M; Balint G; Whaley K
    J Clin Lab Immunol; 1979 Apr; 2(1):15-22. PubMed ID: 95801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.
    Nydegger UE; Lambert PH; Gerber H; Miescher PA
    J Clin Invest; 1974 Aug; 54(2):297-309. PubMed ID: 4847246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on circulating soluble immune complexes of the liver disease. 6. Comparative studies of 125I-pRF inhibition assay, 125I-Clq inhibition assay and 125I-Clq binding assay.
    Narumoto J
    Gastroenterol Jpn; 1981; 16(2):174-85. PubMed ID: 6971771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid phase C1q microassay for the rapid detection of circulating immune complexes.
    Orozco A; Contreras CE; Sánchez P; Meilijson O; Bianco NE
    J Immunol Methods; 1983 Apr; 59(2):237-43. PubMed ID: 6341470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Demonstration of circulating immune complexes using a C1q-solid phase enzyme immunoassay].
    Schössler W; Hiepe F; Courault K; Porstmann B; Apostoloff E
    Biomed Biochim Acta; 1983; 42(7-8):1027-35. PubMed ID: 6360166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of immune complexes by a microplate-adapted C1q-Protein A enzyme-linked-immunosorbent-assay (C1q-PA-ELISA).
    Bjerrum L; Glikmann G; Jensenius JC; Svehag SE
    J Clin Lab Immunol; 1983 Jan; 10(1):53-8. PubMed ID: 6338238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of circulating immune complexes in human sera by enzyme immunoassay.
    Cheung K; O'Kane D; Robinson MF
    Aust J Exp Biol Med Sci; 1982 Dec; 60(6):593-605. PubMed ID: 6820632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical analysis of five immune complex screening assays: patterns of detection in patients with rheumatoid arthritis, systemic lupus erythematosus, infectious endocarditis, and diabetes mellitus.
    Kilpatrick JM; Virella G
    Diagn Immunol; 1983; 1(2):57-63. PubMed ID: 6388965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An enzyme-linked immunoassay for detection of IgG- and C3-containing circulating immune complexes: comparison with a radioimmunoassay and quantitation in patients with rheumatic diseases.
    Panush RS; Somberg LB; Katz P; Longley S
    Diagn Immunol; 1983; 1(4):288-94. PubMed ID: 6388973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The IgG detected in the C1q solid-phase immune-complex assay is not always of immune-complex nature.
    Hack CE; Belmer AJ
    Clin Immunol Immunopathol; 1986 Jan; 38(1):120-8. PubMed ID: 3484437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An extended C1q-binding assay using lactoperoxidase- and chloramine-T-iodinated C1q. Immediate distinction between immune-aggregate-mediated and non-immune-aggregate-mediated C1q binding.
    Spaeth PJ; Corvetta A; Nydegger UE; Montroni M; Buetler R
    Scand J Immunol; 1983 Oct; 18(4):319-28. PubMed ID: 6606219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
    Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
    J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The detection of circulating immune complexes containing C1q and IgG using a new rapid serum ELISA test system.
    Reckel RP; Harris J; Botsko E; Wellerson R; Varga S
    Diagn Immunol; 1984; 2(4):228-37. PubMed ID: 6335421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of the C1q binding assay in the analysis of immune complexes: personal experiences with its clinical use and future prospectives].
    Corvetta A; Spaeth PJ; Panico F; Ghirelli PA; Orecchioni F; Danieli G
    G Clin Med; 1983; 64(9-10):337-48. PubMed ID: 6198235
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancement of Clq binding activity by IgM rheumatoid factor.
    Zilberfarb JL; Andrews BS; Young AC; Davis JS
    J Rheumatol; 1985 Jun; 12(3):444-8. PubMed ID: 3876433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A solid-phase assay for circulating immune complexes using monoclonal rheumatoid factors and peroxidase-linked protein A.
    Davey MP; Korngold L
    J Immunol Methods; 1981; 44(1):87-100. PubMed ID: 7252177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the soluble immune complexes that are detected by three different techniques.
    van der Giessen M; The TH
    Clin Immunol Immunopathol; 1986 Feb; 38(2):244-55. PubMed ID: 3484441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 193.